The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

NTLA FINANCIAL STATEMENTS

Intellia Therapeutics Inc — balance sheet, income statement and cash flow trends

NTLAIntellia Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-400 M-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue59.5 M $Gross Profit-35.3 M $ · -59%Operating Income-423.5 M $ · -712%Pre-tax Income-400 M $ · -672%Net Income to Owners-400 M $ · -672%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue59.5 M $+12.6%
Gross Profit-35.3 M $—
Operating Income-423.5 M $—
EBITDA-285.8 M $—
Net Income to Owners-400 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets857.2 M
  • Equity727.7 M $85%
  • Current Liabilities79.4 M $9%
  • Long-term Liabilities50.1 M $6%

Key Figures

YoY change
Total Assets857.2 M $-4.6%
Total Liabilities129.5 M $-29.5%
Total Equity727.7 M $+1.7%
Cash & ST Investments437.8 M $-4.8%
Total Debt73.4 M $-28.4%
Net Debt-32.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-400 M-200 M0-464 M $Operating17.8 M $Investing380.1 M $Financing-66.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow-464 M $—
Capital Expenditures2.1 M $-34.4%
Free Cash Flow-466.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NTLA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.